Thanks to its newly improved SymTrap extraction technology, functional ingredient supplier Symrise AG (Holzminden, Germany) is now launching Actiplants, a portfolio of bioactive ingredients from natural extracts which the company says are extracted through a highly effective and energy-saving method.
Thanks to its newly improved SymTrap extraction technology, functional ingredient supplier Symrise AG (Holzminden, Germany) is now launching Actiplants, a portfolio of bioactive ingredients from natural extracts which the company says are extracted through a highly effective and energy-saving method.
The company says its patented extraction process is based on an adsorption-desorption method which allows for gentler extraction to isolate healthful ingredients in highly efficient concentrations.
The Actiplants line will feature a variety of healthful ingredients, including bilberry (Vaccinium myrtillus)extract. Increasing research on bilberry is pointing to bilberry’s natural concentration of anthocyanins, believed to promote better eye health, capillary function, and other improved health factors.
“Though important to human health, this group of compounds is only present in bilberries in trace amounts (no more than 0.5%),” states Symrise. “Symrise, however, has managed to raise the concentration to 25% and in some cases to even 36%.”
Symrise’s Hamburg production plant will play host to the company’s largest SymTrap plant.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.
Recent review makes the case for testing omega-3 fatty acid levels in humans
May 23rd 2024The article commissioned by The Global Organization for EPA and DHA Omega-3s (GOED) reviewed the state of omega-3 fatty acid testing, highlighting the value of testing and the commercially available options for diagnostic testing.
Epax launches concentrated oil that combines omegas 3, 9, and 11
May 10th 2024The blend of long-chain polyunsaturated fatty acids and long-chain monounsaturated fatty acids combines the heart and brain health benefits of omegas-3s with the skin and metabolic health benefits of omegas 9 and 11.